Predictors of early hemorrhage in acute promyelocytic leukemia

被引:28
作者
Naymagon, Leonard [1 ]
Moshier, Erin [2 ]
Tremblay, Douglas [1 ]
Mascarenhas, John [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
关键词
Acute promyelocytic leukemia; hemorrhage; disseminated intravascular coagulation; white blood cell count; lactate dehydrogenase; differentiation syndrome; TRANS-RETINOIC ACID; INDUCTION THERAPY; DIFFERENTIATION SYNDROME; ARSENIC TRIOXIDE; RISK; ANTHRACYCLINE; CONSOLIDATION; COAGULOPATHY; PATHOGENESIS; INTERGROUP;
D O I
10.1080/10428194.2019.1581187
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fatal hemorrhage is the most common cause of induction failure and death among patients with acute promyelocytic leukemia (APL). However, there remains no established means of hemorrhagic risk stratification in APL. In this single center retrospective study of 43 patients treated for APL group-based trajectory modeling was used to identify laboratory trends associated with major bleeding. Bleeding risk was significantly associated with particular trends in white blood cell count (WBC) and lactate dehydrogenase level (LDH). Specifically, patients who presented with high WBC and/or LDH, and whose WBC and/or LDH then proceeded to uptrend during the initial days of induction, were significantly more likely to experience major bleeding (p?=?.0111 and p?=?.0143, respectively). Additionally, there appeared to be a temporal association between WBC and LDH trends and major bleeding events. Among nonlaboratory variables, differentiation syndrome (DS) was significantly associated with major bleeding (p?=?.00149).
引用
收藏
页码:2394 / 2403
页数:10
相关论文
共 30 条
[1]   Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience [J].
Ades, Lionel ;
Guerci, Agnes ;
Raffoux, Emmanuel ;
Sanz, Miguel ;
Chevallier, Patrice ;
Lapusan, Simona ;
Recher, Christian ;
Thomas, Xavier ;
Rayon, Consuelo ;
Castaigne, Sylvie ;
Tournilhac, Olivier ;
de Botton, Stephane ;
Ifrah, Norbert ;
Cahn, Jean-Yves ;
Solary, Eric ;
Gardin, Claude ;
Fegeux, Nathalie ;
Bordessoule, Dominique ;
Ferrant, Augustin ;
Meyer-Monard, Sandrine ;
Vey, Norbert ;
Dombret, Herve ;
Degos, Laurent ;
Chevret, Sylvie ;
Fenaux, Pierre .
BLOOD, 2010, 115 (09) :1690-1696
[2]   Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high white blood cell count, late diagnosis and delayed treatment initiation [J].
Breccia, Massimo ;
Latagliata, Roberto ;
Cannella, Laura ;
Minotti, Clara ;
Meloni, Giovanna ;
Lo-Coco, Francesco .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05) :853-854
[3]   The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia [J].
Breen, Karen A. ;
Grimwade, David ;
Hunt, Beverley J. .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (01) :24-36
[4]   Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia [J].
Chang, Hung ;
Kuo, Ming-Chung ;
Shih, Lee-Yung ;
Dunn, Po ;
Wang, Po-Nan ;
Wu, Jin-Hou ;
Lin, Tung-Liang ;
Hung, Yu-Shin ;
Tang, Tzung-Chih .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (04) :321-328
[5]   Bleeding and thrombosis in acute promyelocytic leukemia [J].
Choudhry, Aditi ;
DeLoughery, Thomas G. .
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (06) :596-603
[6]   Acute promyelocytic leukemia: where did we start, where are we now, and the future [J].
Coombs, C. C. ;
Tavakkoli, M. ;
Tallman, M. S. .
BLOOD CANCER JOURNAL, 2015, 5 :e304-e304
[7]   Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia - a single center experience in 34 patients [J].
Dally, N ;
Hoffman, R ;
Haddad, N ;
Sarig, G ;
Rowe, JM ;
Brenner, B .
THROMBOSIS RESEARCH, 2005, 116 (02) :109-114
[8]   Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin [J].
de la Serna, Javier ;
Montesinos, Pau ;
Vellenga, Edo ;
Rayon, Chelo ;
Parody, Ricardo ;
Leon, Angel ;
Esteve, Jordi ;
Bergua, Juan M. ;
Milone, Gustavo ;
Deben, Guillermo ;
Rivas, Concha ;
Gonzalez, Marcos ;
Tormo, Mar ;
Diaz-Mediavilla, Joaquin ;
Gonzalez, Jose D. ;
Negri, Silvia ;
Amutio, Elena ;
Brunet, Salut ;
Lowenberg, Bob ;
Sanz, Miguel A. .
BLOOD, 2008, 111 (07) :3395-3402
[9]   Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia [J].
Kim, Dae-Young ;
Lee, Je-Hwan ;
Lee, Jung-Hee ;
Kim, Sung-Doo ;
Lim, Sung-Nam ;
Choi, Yunsuk ;
Lee, Young-Shin ;
Kang, Young-Ah ;
Seol, Miee ;
Jeon, Mijin ;
Kim, Joo Youn ;
Lee, Kyung-Hwa ;
Lee, Yeon-Joo ;
Lee, Kyoo-Hyung .
LEUKEMIA RESEARCH, 2011, 35 (02) :152-158
[10]   Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry [J].
Lehmann, S. ;
Ravn, A. ;
Carlsson, L. ;
Antunovic, P. ;
Deneberg, S. ;
Mollgard, L. ;
Derolf, A. Rangert ;
Stockelberg, D. ;
Tidefelt, U. ;
Wahlin, A. ;
Wennstrom, L. ;
Hoglund, M. ;
Juliusson, G. .
LEUKEMIA, 2011, 25 (07) :1128-1134